AI assistant
NUFARM LIMITED — Director's Dealing 2008
Nov 25, 2008
65453_rns_2008-11-25_58e0b306-b165-4164-a232-6af736720c76.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Nufarm Limited ACN 091 323 312 103-105 Pipe Road, Laverton North, VIC Australia 3026 Telephone: (03) 9282 1217 Facsimile: (03) 9282 1132 Postal Address: PO Box 103, Laverton, VIC Australia 3028
==> picture [74 x 62] intentionally omitted <==
26 November 2008
On 20 October, we lodged an Appendix 3Y on behalf of Dr WB Goodfellow in respect of Dr Goodfellow’s non beneficial interest in shares owned by the Trustees of the Goodfellow Foundation.
That Appendix 3Y contained a numerical error in respect of the number of shares owned by the Trustees and we now attach a replacement Appendix 3Y which contains the correct number of shares.
==> picture [68 x 58] intentionally omitted <==
RODNEY HEATH Company Secretary
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/9/2001.
Name of entity NUFARM LIMITED ABN 37 091 323 312
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | WILLIAM BRUCE GOODFELLOW |
|---|---|
| Date of last notice | 18/11/08 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Non-beneficial interest arising from the holding of Ordinary Shares in Nufarm by the trustees of The Goodfellow Foundation. The Goodfellow Foundation is associated with the Goodfellow family, of which WB Goodfellow is chairman and a member of the board of trustees. |
| Date of change | 26/11/2008 |
| No. of securities held prior to change |
Direct 71,118 Fully Paid Ordinary Shares Indirect: Pacific Custodians Pty Ltd - 38,987 Fully Paid Ordinary Shares MA Goodfellow - 12,177 Fully Paid Ordinary Shares and 100 NSS St Kentigern Trust - 430,186 Fully Paid Ordinary Shares and 19,727 NSS SulkemCompanyLtd - 113,947 FullyPaidOrdinary Shares |
- See chapter 19 for defined terms.
Appendix 3Y Page 1
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
| Auckland Medical Research Foundation - 25,462 NSS Trustee of the Goodfellow Foundation – 35,367 Fully Paid Ordinary Shares and 1,338 NSS. |
|
|---|---|
| Class | Ordinary |
| Number acquired | Indirect –331 Fully Paid Ordinary Shares |
| Number disposed | Nil |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
$15.10 per share |
| No. of securities held after change |
Direct: 71,971 Fully Paid Ordinary Shares Indirect: Pacific Custodians Pty Ltd – 38,987 Fully Paid Ordinary Shares MA Goodfellow - 12,177 Fully Paid Ordinary Shares and 100 NSS St Kentigern Trust - 430,186 Fully Paid Ordinary Shares and 19,727 NSS Sulkem Company Ltd – 116,479 Fully Paid Ordinary Shares Auckland Medical Research Foundation - 25,462 NSS Trustees of The Goodfellow Foundation - 35,698 Fully Paid Ordinary Shares and 1,338 NSS |
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
Shares issued under the Company’s Share Purchase Plan. |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change
- See chapter 19 for defined terms.
Appendix 3Y Page 2
11/3/2002
Appendix 3Y Change of Director’s Interest Notice
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change
- See chapter 19 for defined terms.
Appendix 3Y Page 3
11/3/2002